Abstract
The effect of phosphate supplementation on bone remodeling was assessed in six mature, healthy beagle dogs. The phosphate supplement was given in divided doses orally, daily for 12 weeks in the form of a neutral potassium phosphate preparation. The dose averaged 108 mg P/kg per day, which is double the normal canine phosphorus intake. Bone remodeling was assessed by measurement, at sacrifice, of areas of cortical bone containing different colorcoded tetracyclines which had been continuously administered during 12-week control and treatment periods; remodeling was assessed kinetically during the control and treatment periods by replicate studies employing47Ca intravenously.
Both techniques demonstrated that the principal effect of phosphate supplementation was a significant stimulation of bone formation. Within cortical bone, formation was doubled, from an average of 2.7% to 5.3% per year. The major location of new bone deposits was endosteal. Whole skeletal mineral accretion, measured kinetically, increased 45% above an average control value of 0.154 g/day. These studies suggest that, in the adult dog, “normal” plasma phosphate levels are suboptimal for new bone formation.
Even with this short duration of administration, phosphate produced microscopic calcification of the renal parenchyma. However, there was no biochemical evidence of renal functional impairment.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Albright, F., Baird, P. C., Cope, O., Bloomberg, E.: Studies on the physiology of the parathyroid glands. IV. Renal complications of hyperparathyroidism. Amer. J. med. Sci.187, 49–65 (1934)
Albright, F., Bauer, W., Claflin, D., Cockrill, J. R.: Studies in parathyroid physiology. III. The effect of phosphate ingestion in clinical hyperparathyroidism. J. clin. Invest.11, 411–435 (1932)
Asher, M. A., Sledge, C. D., Glimcher, M. J.: The effect of inorganic orthophosphate on the rates of collagen formation and degradation in bone and cartilage in tissue culture. J. clin. Endocr.38, 376–389 (1974)
Baylor, C. H., Van Alstine, H. E., Keutmann, E. H., Bassett, S. H.: The fate of intravenously administered calcium. Effect on urinary calcium and phosphorus, fecal calcium and calcium-phosphorus balance. J. clin. Invest.29, 1167–1176 (1950)
Bernstein, D. S., Newton, R.: The effect of oral sodium phosphate on the formation of renal calculi and on idiopathic hypercalciuria. Lancet1966II, 1105–1107
Bruin, W. J., Baylink, D. J., Wergedal, J. E.: Acute inhibition of mineralization and stimulation of bone resorption mediated by hypophosphatemia. Endocrinology96, 394–399 (1975)
Bulger, H. A., Dixon, H. H., Barr, D. P., Schregardus, O.: The functional pathology of hyperparathyroidism. J. clin. Invest.9, 143–190 (1930)
Clark, I.: Effects of dietary and hormonal factors on phosphate metabolism in the rat. In: Phosphate et metabolisme phosphocalcique (Hioco, D. J., ed.), pp. 89–110. Paris: Sandoz 1971
Clark, I., Rivera-Cordero, F.: Prevention of phosphate-induced nephrocalcinosis by parathyroidectomy. Proc. Soc. exp. Biol. (N. Y.)139, 803–805 (1972)
Edwards, N. A., Hodgkinson, A.: Phosphate metabolism in patients with renal calculus. Clin. Sci.29, 93–106 (1965)
Eisenberg, E.: Effect of intravenous phosphate on serum strontium and calcium. New Engl. J. Med.282, 889–892 (1970)
Feinblatt, J., Bélanger, L. F., Rasmussen, H.: Effect of phosphate infusion on bone metabolism and parathyroid hormone action. Amer. J. Physiol.218, 1624–1631 (1970)
Goldsmith, R. S., Ingbar, S. H.: Effects of oral phosphate supplements in demineralizing disorders of bone. J. clin. Invest.45, 1014 (1966)
Goldsmith, R. S., Ingbar, S. H.: Inorganic phosphate treatment of hypercalcemia of diverse etiologies. New Engl. J. Med.274, 1–7 (1966)
Guest, G. M., Rapoport, S.: Role of acid-soluble compounds in red blood cells. Amer. J. Dis. Child.58, 1072–1089 (1939)
Harris, W. H., Haywood, E. A., Lavorgna, J., Hamblen, D. L.: Spatial and temporal variations in cortical bone formation in dogs. J. Bone Jt Surg. A50, 1118–1128 (1968)
Harris, W. H., Heaney, R. P., Jowsey, J., Cockin, J., Akins, C., Graham, J., Weinberg, E. H.: Growth hormone: The effect on skeletal renewal in the adult dog. I. Morphometric studies. Calcif. Tiss. Res.10, 1–13 (1972)
Harris, W. H., Weinberg, E. H.: Microscopic method of measuring increases in cortical bone volume and mass. Calcif. Tiss. Res.8, 190–196 (1972)
Heaney, R. P.: Evaluation and interpretation of calcium-kinetic data in man. Clin. Orthop.31, 153–183 (1963)
Heaney, R. P.: Whole body counting: Analysis of retention data for isotopes having prominent fecal excretion. J. Lab. clin. Med.84, 1–5 (1974)
Hebert, L. A., Lemann, J., Petersen, J. R., Lennon, E. J.: Studies of the mechanisms by which phosphate infusion lowers serum calcium concentration. J. clin. Invest.45, 1886–1894 (1966)
Jenkins, K. J., Phillips, P. H.: The mineral requirements of the dog. II. The relation of calcium, phosphorus and fat levels to minimal calcium and phosphorus requirements. J. Nutr.70, 241–246 (1960)
Jowsey, J., Balasubramaniam, P.: Effect of phosphate supplementation on soft tissue calcification and bone turnover. Clin. Sci.42, 289–299 (1972)
Jowsey, J., Reiss, E., Canterbury, J. M.: Long-term effects of high phosphate intake on parathyroid hormone levels and bone metabolism. Acta orthop. scand.45, 801–808 (1974)
Kistler, H. J.: Treatment of hypercalcemia with inorganic phosphate Helv. med. Acta33, 447–459 (1967)
LaFlamme, G. H., Jowsey, J.: Bone and soft tissue changes with oral phosphate supplements. J. clin. Invest.51, 2834–40 (1972)
Lichtman, M. A.: Hypoalimentation during hyperalimentation. New Engl. J. Med.290, 1432–1433 (1974)
Lichtman, M. A., Mller, D. R., Cohen, J., Waterhouse, C.: Reduced red cell glycolysis, 2,3-diphosphoglycerate and adenosine triphosphate concentration, and increased hemoglobin-oxygen affinity caused by hypophosphatemia. Ann. intern. Med.74, 562–568 (1971)
Lichtman, M. A., Miller, D. R., Freeman, R. B.: Erythrocyte adenosine triphosphate depletion during hypophosphatemia in a uremic subject. New Engl. J. Med.280, 240–244 (1969)
Malm, O. J.: On phosphates and phosphoric acid as dietary factors in the calcium balance of man. Scand. J. clin. Lab. Invest.5, 75–84 (1953)
Massry, S. G., Mueller, E., Silverman, A. G., Kleeman, C. R.: Inorganic phosphate treatment of hypercalcemia. Arch. intern. Med.121, 307–312 (1968)
McLean, F. C., Hinrichs, M. A.: The formation of colloidal calcium phosphate in the blood. Amer. J. Physiol.121, 580–588 (1938)
Milhaud, G., Perault-Staul, A. M., Moukhtar, M. S.: Etude du mecanisme de l'effet hypocalcemiant du phosphate mineral et de l'interaction eventuelle avec la thyrocalcitonine. C.R. Acad. Sci. (Paris)266, 1169–1172 (1968)
Nagant de Deuxchaines, C., Krane, S. M.: The treatment of adult phosphate diabetes and Fanconi syndrome with neutral sodium phosphate. Amer. J. Med.43, 508–543 (1967)
Pechet, M. M., Bobadilla, E., Carroll, E. L., Hesse, R. H.: Regulation of bone resorption and formation. Amer. J. Med.43, 696–710 (1967)
Reiss, E., Canterbury, J. M.: Genesis of hyperparathyroidism. Amer. J. Med.50, 679–685 (1971)
Reiss, E., Canterbury, J. M., Bercovitz, M. A., Kaplan, E. L.: The role of phosphate in the secretion of parathyroid hormone in man. J. clin. Invest.49, 2146–2149 (1970)
Reiss, E., Canterbury, J. M., Kanter, A.: Circulating parathyroid hormone concentration in chronic renal insufficiency. Arch. intern. Med.124, 417–422 (1969)
Salveson, H. A., Hastings, A. B., McIntosh, J. F.: Blood changes and clinical symptoms following oral administration of phosphates. J. biol. Chem.60, 311–326 (1924)
Shackney, S., Hasson, J.: Precipitous fall in serum calcium hypotension, and acute renal failure after intravenous phosphate therapy for hypercalcemia. Ann. intern. Med.66, 906–916 (1967)
Sorenson, J. A., Cameron, J. R.: A reliable in vivo measurement of bone mineral content. J. Bone Jt Surg. A49, 481–497 (1967)
Spencer, H., Menczel, J., Lewin, I., Samachson, J.: Effect of high phosphorus intake on calcium and phosphorus metabolism in man. J. Nutr.86, 125–132 (1965)
Wergedal, J., Stauffer, M., Baylink, D., Rich, C.: Inhibition of bone matrix formation, mineralization and resorption in thyroparathyroidectomized rats. J. clin. Invest.52, 1052–1058 (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Harris, W.H., Heaney, R.P., Davis, L.A. et al. Stimulation of bone formation in vivo by phosphate supplementation. Calc. Tis Res. 22, 85–98 (1977). https://doi.org/10.1007/BF02010349
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02010349